{"count": 15, "results": [{"_id": "30863219", "pmid": 30863219, "pmcid": "PMC6378011", "title": "Imaging the Proangiogenic Effects of Cardiovascular Drugs in a Diabetic Model of Limb Ischemia", "journal": "Contrast Media Mol Imaging", "authors": ["Goggi JL", "Haslop A", "Boominathan R", "Chan K", "Soh V", "Cheng P", "Robins EG", "Bhakoo KK"], "date": "2019-02-03T00:00:00Z", "doi": "10.1155/2019/2538909", "meta_date_publication": "2019", "meta_volume": "2019", "meta_issue": "", "meta_pages": "2538909", "score": 50073.35, "text_hl": "Two routine therapies used in @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular disease@@@ have been shown to significantly increase angiogenesis in preclinical models of @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischemia@@@ and could be rapidly adopted for use in @<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@PAD@@@. @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@Metformin@@@, a widely used antidiabetic drug for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, a 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibitor, used to regulate @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ levels, have previously been shown to enhance recovery from @DISEASE_Acute_Disease @DISEASE_MESH:D000208 @@@acute@@@ @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@limb ischemia@@@ in nondiabetic animals, and pretreatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ has been shown to ameliorate @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@limb ischemia@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Goggi JL, Haslop A, Boominathan R, Chan K, Soh V, Cheng P, Robins EG, Bhakoo KK. Imaging the Proangiogenic Effects of Cardiovascular Drugs in a Diabetic Model of Limb Ischemia Contrast Media Mol Imaging. 2019;2019():2538909. PMID: 30863219", "BibTeX": "@article{30863219, title={Imaging the Proangiogenic Effects of Cardiovascular Drugs in a Diabetic Model of Limb Ischemia}, author={Goggi JL and Haslop A and Boominathan R and Chan K and Soh V and Cheng P and Robins EG and Bhakoo KK}, journal={Contrast Media Mol Imaging}, volume={2019}, pages={2538909}}"}}, {"_id": "14759090", "pmid": 14759090, "title": "The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease.", "journal": "Angiology", "authors": ["Youssef F", "Gupta P", "Seifalian AM", "Myint F", "Mikhailidis DP", "Hamilton G"], "date": "2004-01-01T00:00:00Z", "doi": "10.1177/000331970405500108", "meta_date_publication": "2004 Jan-Feb", "meta_volume": "55", "meta_issue": "1", "meta_pages": "53-62", "score": 50070.496, "text_hl": "The effect of short-term treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on renal function in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@peripheral arterial disease@@@.", "citations": {"NLM": "Youssef F, Gupta P, Seifalian AM, Myint F, Mikhailidis DP, Hamilton G. The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease. Angiology. 2004 Jan-Feb;55(1):53-62. PMID: 14759090", "BibTeX": "@article{14759090, title={The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease.}, author={Youssef F and Gupta P and Seifalian AM and Myint F and Mikhailidis DP and Hamilton G}, journal={Angiology}, volume={55}, number={1}, pages={53-62}}"}}, {"_id": "27423725", "pmid": 27423725, "title": "Effect of Simvastatin Treatment on \"In Vitro\" NLRP1 Inflammasome Expression in Peripheral Arterial Disease.", "journal": "Ann Vasc Surg", "authors": ["Bleda S", "de Haro J", "Lopez de Maturana I", "Varela C", "Ferruelo A", "Acin F"], "date": "2016-10-01T00:00:00Z", "doi": "10.1016/j.avsg.2016.05.090", "meta_date_publication": "2016 Oct", "meta_volume": "36", "meta_issue": "", "meta_pages": "260-264", "score": 50070.367, "text_hl": "Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Treatment on \"In Vitro\" @GENE_NLRP1 @GENE_22861 @@@NLRP1@@@ Inflammasome Expression in @<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@Peripheral Arterial Disease@@@.", "citations": {"NLM": "Bleda S, de Haro J, Lopez de Maturana I, Varela C, Ferruelo A, Acin F. Effect of Simvastatin Treatment on \"In Vitro\" NLRP1 Inflammasome Expression in Peripheral Arterial Disease. Ann Vasc Surg. 2016 Oct;36():260-264. PMID: 27423725", "BibTeX": "@article{27423725, title={Effect of Simvastatin Treatment on \"In Vitro\" NLRP1 Inflammasome Expression in Peripheral Arterial Disease.}, author={Bleda S and de Haro J and Lopez de Maturana I and Varela C and Ferruelo A and Acin F}, journal={Ann Vasc Surg}, volume={36}, pages={260-264}}"}}, {"_id": "25595417", "pmid": 25595417, "title": "High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.", "journal": "Heart", "authors": ["Stoekenbroek RM", "Boekholdt SM", "Fayyad R", "Laskey R", "Tikkanen MJ", "Pedersen TR", "Hovingh GK", "Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group"], "date": "2015-03-01T00:00:00Z", "doi": "10.1136/heartjnl-2014-306906", "meta_date_publication": "2015 Mar", "meta_volume": "101", "meta_issue": "5", "meta_pages": "356-62", "score": 50068.598, "text_hl": "High-dose @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ is superior to moderate-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in preventing @<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@peripheral arterial disease@@@.", "citations": {"NLM": "Stoekenbroek RM, Boekholdt SM, Fayyad R, Laskey R, Tikkanen MJ, Pedersen TR, Hovingh GK, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group. High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease. Heart. 2015 Mar;101(5):356-62. PMID: 25595417", "BibTeX": "@article{25595417, title={High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.}, author={Stoekenbroek RM and Boekholdt SM and Fayyad R and Laskey R and Tikkanen MJ and Pedersen TR and Hovingh GK and Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group}, journal={Heart}, volume={101}, number={5}, pages={356-62}}"}}, {"_id": "21867844", "pmid": 21867844, "title": "Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.", "journal": "J Am Coll Cardiol", "authors": ["West AM", "Anderson JD", "Epstein FH", "Meyer CH", "Wang H", "Hagspiel KD", "Berr SS", "Harthun NL", "Weltman AL", "Dimaria JM", "Hunter JR", "Christopher JM", "Kramer CM"], "date": "2011-08-30T00:00:00Z", "doi": "10.1016/j.jacc.2011.04.034", "meta_date_publication": "2011 Aug 30", "meta_volume": "58", "meta_issue": "10", "meta_pages": "1068-76", "score": 50062.848, "text_hl": "METHODS: Sixty-eight @SPECIES_9606 @@@patients@@@ with mild to moderate symptomatic @<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@PAD@@@ (age 65 +- 11 years; ankle-brachial index [ABI] 0.69 +- 0.14) were studied at baseline and annually for 2 years after beginning @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg (n = 20) or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg/@CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ 10 mg (n = 18) if statin naive, or @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ 10 mg (n = 30) if taking a statin. ", "citations": {"NLM": "West AM, Anderson JD, Epstein FH, Meyer CH, Wang H, Hagspiel KD, Berr SS, Harthun NL, Weltman AL, Dimaria JM, Hunter JR, Christopher JM, Kramer CM. Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease. J Am Coll Cardiol. 2011 Aug 30;58(10):1068-76. PMID: 21867844", "BibTeX": "@article{21867844, title={Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.}, author={West AM and Anderson JD and Epstein FH and Meyer CH and Wang H and Hagspiel KD and Berr SS and Harthun NL and Weltman AL and Dimaria JM and Hunter JR and Christopher JM and Kramer CM}, journal={J Am Coll Cardiol}, volume={58}, number={10}, pages={1068-76}}"}}, {"_id": "23950601", "pmid": 23950601, "title": "Lymphocyte-suppressing action of simvastatin in patients with isolated hypertriglyceridemia.", "journal": "Pharmacol Rep", "authors": ["Krysiak R", "Okopień B"], "date": "2013-01-01T00:00:00Z", "doi": "10.1016/s1734-1140(13)71056-9", "meta_date_publication": "2013", "meta_volume": "65", "meta_issue": "3", "meta_pages": "756-60", "score": 50061.28, "text_hl": "METHODS: The study included 46 @SPECIES_9606 @@@patients@@@ with elevated @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglyceride@@@ levels and @<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@peripheral artery stenosis@@@, randomly assigned to receive @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or placebo. ", "citations": {"NLM": "Krysiak R, Okopień B. Lymphocyte-suppressing action of simvastatin in patients with isolated hypertriglyceridemia. Pharmacol Rep. 2013;65(3):756-60. PMID: 23950601", "BibTeX": "@article{23950601, title={Lymphocyte-suppressing action of simvastatin in patients with isolated hypertriglyceridemia.}, author={Krysiak R and Okopień B}, journal={Pharmacol Rep}, volume={65}, number={3}, pages={756-60}}"}}, {"_id": "17398372", "pmid": 17398372, "title": "Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions.", "journal": "J Vasc Surg", "authors": ["Heart Protection Study Collaborative Group"], "date": "2007-04-01T00:00:00Z", "doi": "10.1016/j.jvs.2006.12.054", "meta_date_publication": "2007 Apr", "meta_volume": "45", "meta_issue": "4", "meta_pages": "645-654; discussion 653-4", "score": 50061.01, "text_hl": "Randomized trial of the effects of @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@-lowering with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on peripheral vascular and other major vascular outcomes in 20,536 people with @<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@peripheral arterial disease@@@ and other high-risk conditions.", "citations": {"NLM": "Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007 Apr;45(4):645-654; discussion 653-4. PMID: 17398372", "BibTeX": "@article{17398372, title={Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions.}, author={Heart Protection Study Collaborative Group}, journal={J Vasc Surg}, volume={45}, number={4}, pages={645-654; discussion 653-4}}"}}, {"_id": "24080592", "pmid": 24080592, "title": "Effect of simvastatin on hemostasis in patients with isolated hypertriglyceridemia.", "journal": "Pharmacology", "authors": ["Krysiak R", "Okopien B"], "date": "2013-01-01T00:00:00Z", "doi": "10.1159/000341909", "meta_date_publication": "2013", "meta_volume": "92", "meta_issue": "3-4", "meta_pages": "187-90", "score": 50060.438, "text_hl": "METHODS: The study included 39 @SPECIES_9606 @@@patients@@@ with elevated @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglyceride@@@ levels and @<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@peripheral artery sclerosis@@@, treated for 90 days with either @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (40 mg daily) or placebo. ", "citations": {"NLM": "Krysiak R, Okopien B. Effect of simvastatin on hemostasis in patients with isolated hypertriglyceridemia. Pharmacology. 2013;92(3-4):187-90. PMID: 24080592", "BibTeX": "@article{24080592, title={Effect of simvastatin on hemostasis in patients with isolated hypertriglyceridemia.}, author={Krysiak R and Okopien B}, journal={Pharmacology}, volume={92}, number={3-4}, pages={187-90}}"}}, {"_id": "23159435", "pmid": 23159435, "title": "Monocyte-suppressing effects of simvastatin in patients with isolated hypertriglyceridemia.", "journal": "Eur J Intern Med", "authors": ["Krysiak R", "Okopien B"], "date": "2013-04-01T00:00:00Z", "doi": "10.1016/j.ejim.2012.10.010", "meta_date_publication": "2013 Apr", "meta_volume": "24", "meta_issue": "3", "meta_pages": "255-9", "score": 50060.273, "text_hl": "METHODS: Our study included 43 subjects with isolated @DISEASE_Hypertriglyceridemia @DISEASE_MESH:D015228 @@@hypertriglyceridemia@@@ and @<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@peripheral artery stenosis@@@ randomly allocated to one of two groups, treated for 12 weeks with either @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (40 mg twice daily) or placebo. ", "citations": {"NLM": "Krysiak R, Okopien B. Monocyte-suppressing effects of simvastatin in patients with isolated hypertriglyceridemia. Eur J Intern Med. 2013 Apr;24(3):255-9. PMID: 23159435", "BibTeX": "@article{23159435, title={Monocyte-suppressing effects of simvastatin in patients with isolated hypertriglyceridemia.}, author={Krysiak R and Okopien B}, journal={Eur J Intern Med}, volume={24}, number={3}, pages={255-9}}"}}, {"_id": "17943736", "pmid": 17943736, "title": "Lipid-lowering for peripheral arterial disease of the lower limb.", "journal": "Cochrane Database Syst Rev", "authors": ["Aung PP", "Maxwell HG", "Jepson RG", "Price JF", "Leng GC"], "date": "2007-10-17T00:00:00Z", "doi": "10.1002/14651858.CD000123.pub2", "meta_date_publication": "2007 Oct 17", "meta_volume": "2007", "meta_issue": "4", "meta_pages": "CD000123", "score": 50054.13, "text_hl": "It may also reduce cardiovascular events and/or local disease progression in people with lower limb @<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@peripheral arterial disease@@@ (@<m>DISEASE_Peripheral_Arterial_Disease</m> @DISEASE_MESH:D058729 @@@PAD@@@). ", "citations": {"NLM": "Aung PP, Maxwell HG, Jepson RG, Price JF, Leng GC. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD000123. PMID: 17943736", "BibTeX": "@article{17943736, title={Lipid-lowering for peripheral arterial disease of the lower limb.}, author={Aung PP and Maxwell HG and Jepson RG and Price JF and Leng GC}, journal={Cochrane Database Syst Rev}, volume={2007}, number={4}, pages={CD000123}}"}}]}